256 related articles for article (PubMed ID: 23018911)
1. Expression of the nuclear factor-κB inhibitor A20 is altered in the cystic fibrosis epithelium.
Kelly C; Williams MT; Mitchell K; Elborn JS; Ennis M; Schock BC
Eur Respir J; 2013 Jun; 41(6):1315-23. PubMed ID: 23018911
[TBL] [Abstract][Full Text] [Related]
2. Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation.
Bannon A; Zhang SD; Schock BC; Ennis M
Med Princ Pract; 2015; 24(4):301-10. PubMed ID: 25925366
[TBL] [Abstract][Full Text] [Related]
3. Expression of the inflammatory regulator A20 correlates with lung function in patients with cystic fibrosis.
Kelly C; Williams MT; Elborn JS; Ennis M; Schock BC
J Cyst Fibros; 2013 Jul; 12(4):411-5. PubMed ID: 23164641
[TBL] [Abstract][Full Text] [Related]
4. A20 overexpression inhibits lipopolysaccharide-induced NF-κB activation, TRAF6 and CD40 expression in rat peritoneal mesothelial cells.
Zou XL; Pei DA; Yan JZ; Xu G; Wu P
Int J Mol Sci; 2014 Apr; 15(4):6592-608. PubMed ID: 24747594
[TBL] [Abstract][Full Text] [Related]
5. Connectivity mapping (ssCMap) to predict A20-inducing drugs and their antiinflammatory action in cystic fibrosis.
Malcomson B; Wilson H; Veglia E; Thillaiyampalam G; Barsden R; Donegan S; El Banna A; Elborn JS; Ennis M; Kelly C; Zhang SD; Schock BC
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3725-34. PubMed ID: 27286825
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling.
Shembade N; Parvatiyar K; Harhaj NS; Harhaj EW
EMBO J; 2009 Mar; 28(5):513-22. PubMed ID: 19131965
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.
Li P; Wang Y; Turner JH
Int Forum Allergy Rhinol; 2015 Jul; 5(7):583-9. PubMed ID: 25907801
[TBL] [Abstract][Full Text] [Related]
8. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
Sisto M; Barca A; Lofrumento DD; Lisi S
Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
[TBL] [Abstract][Full Text] [Related]
9. A20 inhibits toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells.
Gon Y; Asai Y; Hashimoto S; Mizumura K; Jibiki I; Machino T; Ra C; Horie T
Am J Respir Cell Mol Biol; 2004 Sep; 31(3):330-6. PubMed ID: 15142865
[TBL] [Abstract][Full Text] [Related]
10. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
[TBL] [Abstract][Full Text] [Related]
11. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
Wertz IE; O'Rourke KM; Zhou H; Eby M; Aravind L; Seshagiri S; Wu P; Wiesmann C; Baker R; Boone DL; Ma A; Koonin EV; Dixit VM
Nature; 2004 Aug; 430(7000):694-9. PubMed ID: 15258597
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Low Expression of A20 in Tumor Necrosis Factor-α-stimulated SLE Monocytes Mediates Sustained NF-κB Inflammatory Response.
Shi X; Qian T; Li M; Chen F; Chen Y; Hao F
Immunol Invest; 2015; 44(5):497-508. PubMed ID: 26107748
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 4 is not targeted to the lysosome in cystic fibrosis airway epithelial cells.
Kelly C; Canning P; Buchanan PJ; Williams MT; Brown V; Gruenert DC; Elborn JS; Ennis M; Schock BC
Am J Physiol Lung Cell Mol Physiol; 2013 Mar; 304(5):L371-82. PubMed ID: 23316065
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
[TBL] [Abstract][Full Text] [Related]
15. A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions.
Heyninck K; Beyaert R
Trends Biochem Sci; 2005 Jan; 30(1):1-4. PubMed ID: 15653317
[TBL] [Abstract][Full Text] [Related]
16. A20 is induced by Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 and blocks K13-induced nuclear factor-kappaB in a negative feedback manner.
Matta H; Gopalakrishnan R; Punj V; Yi H; Suo Y; Chaudhary PM
J Biol Chem; 2011 Jun; 286(24):21555-64. PubMed ID: 21531730
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.
Shembade N; Ma A; Harhaj EW
Science; 2010 Feb; 327(5969):1135-9. PubMed ID: 20185725
[TBL] [Abstract][Full Text] [Related]
18. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
Verstrepen L; Carpentier I; Verhelst K; Beyaert R
Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
[TBL] [Abstract][Full Text] [Related]
19. A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation.
Oshima N; Ishihara S; Rumi MA; Aziz MM; Mishima Y; Kadota C; Moriyama I; Ishimura N; Amano Y; Kinoshita Y
Clin Exp Immunol; 2010 Feb; 159(2):185-98. PubMed ID: 19912257
[TBL] [Abstract][Full Text] [Related]
20. The seventh zinc finger motif of A20 is required for the suppression of TNF-α-induced apoptosis.
Yamaguchi N; Yamaguchi N
FEBS Lett; 2015 May; 589(12):1369-75. PubMed ID: 25911380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
